Publications by authors named "S Exarchou"
Objective: To compare spinal symptoms and spinal/hip mobility at baseline and 2 years in early axial spondyloarthritis (axSpA) and non-axSpA chronic back pain (BP) patients.
Methods: Baseline and 2 years data of the SPondyloarthritis Caught Early cohort were analysed. Outcomes assessed: overall BP, BP at night, morning stiffness (MS) intensity, MS duration, occiput-to-wall distance (OWD), cervical rotation, chest expansion, lateral spinal flexion (LSF), modified Schober test (mSchober), intermalleolar distance (IMD) and Bath Ankylosing Spondylitis Metrology Index (BASMI).
Article Synopsis
- This study investigates the relationship between systemic inflammation and cholesterol levels in early axial spondyloarthritis (axSpA), an area that has not been extensively researched before.* -
- The research examined 64 patients, finding that higher levels of C-reactive protein (CRP) were associated with lower total cholesterol (TC) and two types of apolipoproteins (ApoA1 and ApoB), especially after adjusting for age, sex, and other factors.* -
- The results suggest that the "lipid paradox" seen in other inflammatory conditions also applies to early axSpA, highlighting the need to consider lipid levels when assessing cardiovascular disease risk in these patients.*
Article Synopsis
- The study looked at four different groups of people with chronic back pain to see if their conditions changed over 2 years.
- They used information from doctors and tests to understand if people might switch from one group to another.
- After 2 years, the results showed that most people stayed in the same group, meaning it's unlikely for someone to suddenly develop new signs of their condition after being checked initially.
Objective: Prior incidence estimates of psoriatic arthritis (PsA) vary considerably. We aimed to assess the annual incidence of clinically diagnosed PsA among adults in Sweden in 2014-2016, overall and stratified by age/sex/education/geography, and to investigate potential time trends in incidence in 2006-2018. Use of disease-modifying antirheumatic drugs (DMARDs) during the 2 years after diagnosis was also examined.
View Article and Find Full Text PDFObjective: To compare health-related quality of life (HRQoL) and work productivity in axial spondyloarthritis (axSpA) and non-axSpA patients with chronic back pain of < 2 years (2 y).
Methods: Baseline and 2 y data of patients included in the SPondyloArthritis Caught Early cohort were analyzed. HRQoL was assessed by the physical (PCS) and mental component summary (MCS) scores of the 36-Item Short-Form Health Survey; and presenteeism, absenteeism, work productivity loss (WPL) and activity impairment (AI) by the Work Productivity and Activity Impairment questionnaire.